Volver a Agenda
Session Chair(s)
Kenneth Getz, MBA
Tufts Center for the Study of Drug Development
Tufts University School of Medicine, United States
Learning Objective : Identify shifts in pharmaceutical R&D; Discuss the impact of these changes on the R&D landscape; Examine the role of small and specialty pharma in the discovery, development, and commercialization of new medical products.
Speaker(s)
Panelist
Kenneth I. Kaitin, PHD
Tufts Center for the Study of Drug Development, United States
Professor and Senior Fellow
Panelist
Ellen G Feigal, MD, MSC
NDA Partners LLC, United States
Principal
Panelist
David G Shoemaker, PHD
Rho, Inc., United States
Senior Vice President, R&D
Panelist
Bruce M. Wagman, MBA, RN, RAC
Labcorp Drug Development, United States
¿Tiene una cuenta?